Aim: We investigated outcomes in patients with advanced non-small-cell lung cancer (NSCLC) and peritoneal involvement. Patients & methods: NSCLC patients with peritoneal carcinomatosis (PC) were included. We evaluated mOS1 (overall survival [OS] from NSCLC diagnosis) and mOS2 (OS from diagnosis of PC). Results: In total, 60 NSCLC patients were diagnosed with PC, 12 (20%) patients had a diagnosis of NSCLC and synchronous PC with a median OS of 9 months. Smokers had a shorter mOS1 and mOS2 compared with never-smokers; EGFR-mutated patients on tyrosine kinase inhibitors had longer mOS1 and mOS2 than EGFR wild-type patients. Conclusion: Metachronous PC is correlated to a short survival, irrespective of treatment line. Never-smokers and EGFR-mutated patients had improved mOS1 and mOS2 when compared with smokers and EGFR wild-type population

Abbate, M., Cortinovis, D., Tiseo, M., Vavalà, T., Cerea, G., Toschi, L., et al. (2019). Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. FUTURE ONCOLOGY, 15(9), 989-994 [10.2217/fon-2018-0469].

Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review

Cortinovis DL;Bidoli P
Ultimo
2019

Abstract

Aim: We investigated outcomes in patients with advanced non-small-cell lung cancer (NSCLC) and peritoneal involvement. Patients & methods: NSCLC patients with peritoneal carcinomatosis (PC) were included. We evaluated mOS1 (overall survival [OS] from NSCLC diagnosis) and mOS2 (OS from diagnosis of PC). Results: In total, 60 NSCLC patients were diagnosed with PC, 12 (20%) patients had a diagnosis of NSCLC and synchronous PC with a median OS of 9 months. Smokers had a shorter mOS1 and mOS2 compared with never-smokers; EGFR-mutated patients on tyrosine kinase inhibitors had longer mOS1 and mOS2 than EGFR wild-type patients. Conclusion: Metachronous PC is correlated to a short survival, irrespective of treatment line. Never-smokers and EGFR-mutated patients had improved mOS1 and mOS2 when compared with smokers and EGFR wild-type population
Articolo in rivista - Articolo scientifico
non-small-cell lung cancer
English
2019
15
9
989
994
none
Abbate, M., Cortinovis, D., Tiseo, M., Vavalà, T., Cerea, G., Toschi, L., et al. (2019). Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. FUTURE ONCOLOGY, 15(9), 989-994 [10.2217/fon-2018-0469].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/260522
Citazioni
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
Social impact